# FDA 483 - Kolmar Korea Co. Ltd. - September 28, 2017

Source: https://www.globalkeysolutions.net/records/483/kolmar-korea-co-ltd/4f9f7dcf-0d54-4666-8711-6a7c9f087cc4

> FDA 483 for Kolmar Korea Co. Ltd. on September 28, 2017. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kolmar Korea Co. Ltd.
- Inspection Date: 2017-09-28
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [WARNING_LETTER - 2017-09-28](https://www.globalkeysolutions.net/records/warning_letter/kolmar-korea-co-ltd/8aeba44d-2fa4-40b3-8f5a-288ca14d2853)
- [483 - 2019-07-05](https://www.globalkeysolutions.net/records/483/kolmar-korea-co-ltd/0c055ad2-35dd-41b2-8097-94af2af70516)

## Related Officers

- [Pratik S. Upadhyay](https://www.globalkeysolutions.net/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)

Company: https://www.globalkeysolutions.net/companies/kolmar-korea-co-ltd/1593ea1f-ab89-4e5c-852b-2ccd0ce714af

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd